1. Home
  2. CACC vs LNTH Comparison

CACC vs LNTH Comparison

Compare CACC & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credit Acceptance Corporation

CACC

Credit Acceptance Corporation

HOLD

Current Price

$475.59

Market Cap

5.0B

Sector

Finance

ML Signal

HOLD

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

HOLD

Current Price

$67.47

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CACC
LNTH
Founded
1972
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.4B
IPO Year
1992
2015

Fundamental Metrics

Financial Performance
Metric
CACC
LNTH
Price
$475.59
$67.47
Analyst Decision
Sell
Strong Buy
Analyst Count
2
6
Target Price
$465.00
$78.00
AVG Volume (30 Days)
124.0K
1.1M
Earning Date
01-29-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
151.44
N/A
EPS
37.89
2.39
Revenue
$1,232,900,000.00
$1,525,933,000.00
Revenue This Year
$129.15
$0.01
Revenue Next Year
$1.97
$0.52
P/E Ratio
$12.57
$28.23
Revenue Growth
45.72
1.95
52 Week Low
$401.90
$47.25
52 Week High
$560.00
$111.29

Technical Indicators

Market Signals
Indicator
CACC
LNTH
Relative Strength Index (RSI) 60.60 61.85
Support Level $450.53 $66.36
Resistance Level $483.72 $70.33
Average True Range (ATR) 13.34 1.67
MACD 1.52 -0.20
Stochastic Oscillator 83.61 60.37

Price Performance

Historical Comparison
CACC
LNTH

About CACC Credit Acceptance Corporation

Credit Acceptance Corp is a consumer finance company that specializes in automobile loans. These loans are offered through a U.S. nationwide network of automobile dealers that benefit from sales of vehicles to consumers who could otherwise not obtain financing. The company also benefits from repeat and referral sales, and from sales to customers responding to advertisements for financing, but qualify for traditional financing. The company derives its revenue from finance charges, premiums earned on the reinsurance of vehicle service contracts, and other fees. Of these, financing charges, including servicing fees, are by far a source of revenue.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Share on Social Networks: